Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Platelet and Immune Characteristics of Patients with Immune Thrombocytopaenia Non Responders to Therapeutic Treatments

Elena Monzón Manzano, Raul Justo Sanz, Diana Hernández, Teresa Álvarez Roman, Ihosvany Fernandez-Bello, Mónica Martín, Larissa Valor, María Isabel Rivas Pollmar, Miguel A Canales, MD PhD, Victor Jimenez-Yuste, Nora Butta, PhD

Blood (2019) 134 (Supplement_1): 1089.

https://doi.org/10.1182/blood-2019-125772

Published: 2019

Journal Articles

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

Leona Raskova Kafkova, MSc, PhD, Diana Brokesova, MSc, Zbynek Novak, MD, Milan Raska, Prof. MD MSc, PhD, Dagmar Pospisilova, Prof MD PhD, Jana Volejnikova, MD

Blood (2019) 134 (Supplement_1): 221.

https://doi.org/10.1182/blood-2019-122095

Published: 2019

Journal Articles

Use of Eculizumab in a Patient with Refractory Autoimmune Hemolytic Anemia with Heterozygous NFκB1 Mutation

Katharine Halligan, MD PhD, Lana Vasiljevic, Phillip Roehrs, MD, Andrew Mcginnitie, MD, Sung-Yun Pai, MD, Rachael F. Grace, MD, Maria Olivares Boucher, MD, Lauren Weintraub, MD

Blood (2017) 130 (Supplement 1): 4743.

https://doi.org/10.1182/blood.V130.Suppl_1.4743.4743

Published: 2017

Journal Articles

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Morie A. Gertz, MD MACP, Haiyan Qiu, PhD, Laura Kendall, Mario Saltarelli, MDPhD, Ted Yednock, PhD, Sethu Sankaranarayanan, PhD

Blood (2016) 128 (22): 1265.

https://doi.org/10.1182/blood.V128.22.1265.1265

Published: 2016

Journal Articles

Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood . 1973;42(4): 541-549 .

Blood (2016) 128 (15): 1905.

https://doi.org/10.1182/blood-2016-08-736009

Published: 2016

Journal Articles

Therapeutic Rationale and Clinical Development of TNT009, an Upstream Classical Pathway Inhibitor, for Cold Agglutinin Disease

Ulrich Jaeger, MD, Eileen L Rose, Andrew Singh, Sebastian H A Feickert, Simon Panzer, Bernd Jilma, MD, James C. Gilbert, MD, Sandip Panicker, PhD

Blood (2015) 126 (23): 3560.

https://doi.org/10.1182/blood.V126.23.3560.3560

Published: 2015

Journal Articles

Complex Relationship of Blood Group H, ABO Glycans, and Von Willebrand Factor Levels

Andy Itsara, MDPhD, Jill M. Johnsen, MD, Kerry W Lannert, Katherine Odem-Davis, PhD, Ayse Bilge Ozel, PhD, Karl C. Desch, MD, Thomas Walsh, BS

Blood (2015) 126 (23): 2242.

https://doi.org/10.1182/blood.V126.23.2242.2242

Published: 2015

Journal Articles

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Alexander Röth, MD, Martin Bommer, MD, Andreas Hüttmann, MD, Dörte Herich-Terhürne, Nils Kuklik, PhD, Lenz Veronika, Hubert Schrezenmeier, MD, Ulrich Dührsen, MD

Blood (2015) 126 (23): 274.

https://doi.org/10.1182/blood.V126.23.274.274

Published: 2015

Journal Articles

Platelet Desialylation Is Closely Associated with Cytotoxic T Lymphocyte-Mediated Platelet Destruction in Immune Thrombocytopenia

Jihua Qiu, Linlin Shao, Hai Zhou, Xin Wang, Jun Peng, MD, Ming Hou, MD

Blood (2014) 124 (21): 463.

https://doi.org/10.1182/blood.V124.21.463.463

Published: 2014

Journal Articles

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Meng Wang, MD PhD, Wenjia Wang, PhD, Ayesha Abeywardane, MD, Malinthi Adikarama, MD, Donal McLornan, MD PhD FRCPath, Kavita Raj, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Stephen Devereux, MD PhD FRCPath, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MD FRCP, FRCPath, Victoria T Potter, MD FRCPA, FRACP, Aleksandar Mijovic

Blood (2014) 124 (21): 2512.

https://doi.org/10.1182/blood.V124.21.2512.2512

Published: 2014

Journal Articles

Glycosylation-Related Gene Expression Is Dysregulated in Multiple Myeloma and Overexpression of the Sialyltransferase ST3GAL6 Is Associated with Inferior Survival.

Siobhan V Glavey, M.B., BCh, BAO, BSc, Stephen Cunningham, PhD, Laura S Murillo, PhD, Catherine Loughrey, MSc, Ping Wu, MBBS, MSc, Michael Cairns, PhD, Satbir Kaur Gill, MSc, Anja Kruger, MSc, Jared Q Gerlach, PhD, Marian Kane, PhD, Gareth J. Morgan, MD PhD, Lokesh Joshi, PhD, Michael E O'Dwyer, MD, FRCPI, FRCPath

Blood (2012) 120 (21): 2931.

https://doi.org/10.1182/blood.V120.21.2931.2931

Published: 2012

Journal Articles

Impaired Platelet Attack by fibronectin Binding Partner Msb2 of Candida Albicans

Volker R. Stoldt, PhD, Khon C. Huynh, MSci, Rudiger E. Scharf, MD, FAHA

Blood (2012) 120 (21): 3299.

https://doi.org/10.1182/blood.V120.21.3299.3299

Published: 2012

Journal Articles

Variation of Both Blood Group H and ABO Glycans Is Associated with VWF Levels

Jill M. Johnsen, MD, Kerry W Lannert, Ermias Yohannes, Xiomara Castillo, Karl C. Desch, MD

Blood (2012) 120 (21): 3314.

https://doi.org/10.1182/blood.V120.21.3314.3314

Published: 2012

Journal Articles

Unrelated Donor T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Advanced Myelodysplastic Syndromes (MDS): The MSKCC Experience

Stephen S. Chung, MD, Jenna D Goldberg, MD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD, PhD, Sean Devlin, PhD, Farid Boulad, MD, Miguel Perales, MD, Nancy A. Kernan, MD, Doris M Ponce, MD, Trudy N Small, MD, Guenther Koehne, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP, Richard J. O'Reilly, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 1996.

https://doi.org/10.1182/blood.V120.21.1996.1996

Published: 2012

Journal Articles

NRAS:BCL-2 Complex Localization Determines Anti-Apoptotic Features Associated with Progressive Disease in Myelodysplastic Syndromes (MDS)

Blood (2012) 120 (21): 3835.

https://doi.org/10.1182/blood.V120.21.3835.3835

Published: 2012

Journal Articles

T-Cell Depleted (TCD) Hematopoietic Stem Cell (HSC) Boosts From the Original Donor without Conditioning for Poor Graft Function (PGF) Following Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

Michael A. Rosenzweig, MD, Nancy A. Kernan, MD, Trudy N Small, MD, Molly Maloy, Ann A. Jakubowski, MD, PhD, Esperanza B Papadopoulos, MD, Miguel-Angel Perales, MD, Farid Boulad, MD, Sergio Giralt, MD, James W Young, MD, Richard J. O'Reilly, MD, Hugo R Castro-Malaspina, MD

Blood (2011) 118 (21): 1942.

https://doi.org/10.1182/blood.V118.21.1942.1942

Published: 2011

Journal Articles

Temperature Cycling Improves In Vivo recovery of Cold Stored Human Platelets

Fei Xu, PhD, Monique Gelderman-Fuhrmann, PhD, John Farrell, BA, Jaroslav Vostal, MD, PhD

Blood (2011) 118 (21): 720.

https://doi.org/10.1182/blood.V118.21.720.720

Published: 2011

Journal Articles

Improved Survival in Patients with Refractory Cytopenias (Low Risk Myelodysplastic Syndrome - MDS) Treated with Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants (allo TCD-HSCTs),

Amy Jhaveri, Esperanza B Papadopoulos, MD, Ann A Jakubowski, MD, PhD, Farid Boulad, MD, Nancy A. Kernan, MD, Trudy N Small, MD, Miguel-Angel Perales, MD, Molly Maloy, Carmen Montes-Gaisan, MD, Richard J. O'Reilly, MD, James W Young, MD, H.R. Castro-Malaspina, MD

Blood (2011) 118 (21): 3831.

https://doi.org/10.1182/blood.V118.21.3831.3831

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for the Treatment of Children with Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) In First Remission (CR1)

Farid Boulad, MD, Nancy A Kernan, MD, Peter G Steinherz, MD, Susan E Prockop, MD, Andromachi Scaradavou, MD, Trudy N Small, MD, Rachel Kobos, MD, Neerav Shukla, MD, Carolyn Doorish, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 3546.

https://doi.org/10.1182/blood.V116.21.3546.3546

Published: 2010

Journal Articles

Rituximab in Lymphoma Associated Auto-Immune Haemolytic Anemia

Amit Bhargava, MD, Nirupma Banerjee

Blood (2010) 116 (21): 4923.

https://doi.org/10.1182/blood.V116.21.4923.4923

Published: 2010

NARROW

Platelet and Immune Characteristics of Patients with Immune Thrombocytopaenia Non Responders to Therapeutic Treatments

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

Use of Eculizumab in a Patient with Refractory Autoimmune Hemolytic Anemia with Heterozygous NFκB1 Mutation

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood . 1973;42(4): 541-549 .

Therapeutic Rationale and Clinical Development of TNT009, an Upstream Classical Pathway Inhibitor, for Cold Agglutinin Disease

Complex Relationship of Blood Group H, ABO Glycans, and Von Willebrand Factor Levels

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Platelet Desialylation Is Closely Associated with Cytotoxic T Lymphocyte-Mediated Platelet Destruction in Immune Thrombocytopenia

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Glycosylation-Related Gene Expression Is Dysregulated in Multiple Myeloma and Overexpression of the Sialyltransferase ST3GAL6 Is Associated with Inferior Survival.

Impaired Platelet Attack by fibronectin Binding Partner Msb2 of Candida Albicans

Variation of Both Blood Group H and ABO Glycans Is Associated with VWF Levels

Unrelated Donor T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Advanced Myelodysplastic Syndromes (MDS): The MSKCC Experience

NRAS:BCL-2 Complex Localization Determines Anti-Apoptotic Features Associated with Progressive Disease in Myelodysplastic Syndromes (MDS)

T-Cell Depleted (TCD) Hematopoietic Stem Cell (HSC) Boosts From the Original Donor without Conditioning for Poor Graft Function (PGF) Following Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

Temperature Cycling Improves In Vivo recovery of Cold Stored Human Platelets

Improved Survival in Patients with Refractory Cytopenias (Low Risk Myelodysplastic Syndrome - MDS) Treated with Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants (allo TCD-HSCTs),

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for the Treatment of Children with Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) In First Remission (CR1)

Rituximab in Lymphoma Associated Auto-Immune Haemolytic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only